03.13.26 -- The Latest On RBM Uptake? Tufts Says Most, But Not All, Pharma On Board

Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

Transform your clinical trial planning with AI-driven, predictive intelligence to design smarter studies, reduce risk, accelerate enrollment, and turn growing complexity into evidence-based decisions.

Early biostatistical input strengthens trial design, reduces risk, and ensures meaningful outcomes while strategic involvement drives smarter decisions. Learn why timing and collaboration matter.

In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.

As one of the world’s largest and most experienced safety and PV organizations, unearth how this provider is bringing extensive expertise and regulatory intelligence to every industry engagement.